The apolipoprotein E (apoE)–/– mice were systemically infused with Ang II via subcutaneous osmotic pumps over a prolonged period, the advantage of which is the presence of atherosclerosis, a risk factor shared with human patients (King et al., 2009; Sénémaud et al., 2017). This evidence concerns the gene APOE and atherosclerosis.